Clinical Study Protocol for the Treatment of ND-AML and RR-AML With KMT2A Gene Abnormalities Using VHEA.
Clinical trial NCT06328179 · RECRUITING
Trial details
- NCT number
- NCT06328179
- Sponsor
- Huai'an First People's Hospital
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-24
- Primary completion
- 2027-12-30
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.